A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)

Clinical trial NCT01116141 · COMPLETED

Trial details

NCT number: NCT01116141
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2010-09-01
Primary completion: 2012-04-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.